YSB Inc. (HKG:9885)

Market Cap	2.26B -59.2%
Revenue (ttm)	24.72B +13.1%
Net Income	214.37M +115.1%
EPS	0.31 +107.8%
Shares Out	680.59M
PE Ratio	10.69
Forward PE	n/a
Dividend	0.13 (3.86%)
Ex-Dividend Date	May 26, 2026

Volume	1,199,000
Open	3.360
Previous Close	3.315
Day's Range	3.250 - 3.360
52-Week Range	2.960 - 8.310
Beta	0.44
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About YSB Inc.

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2015
• Employees: 6,795
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9885

Financial Performance

In 2025, YSB Inc.'s revenue was 20.97 billion, an increase of 17.13% compared to the previous year's 17.90 billion. Earnings were 152.97 million, an increase of 409.66%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error